Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids

Journal of Proteome Research

Volumn 8, Issue 2, 2009, Pages 620-630

  White, Krista Y ^a   Rodemich, Lucy ^b   Nyalwidhe, Julius O ^a   Comunale, Mary Ann ^b   Clements, Mary Ann ^a   Lance, Raymond S ^a,c   Schehhammer, Paul F ^a,c   Mehta, Anand S ^b   Semmes, O John ^a   Drake, Richard R ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Drexel Institute for Biotechnology and Virology Research   (United States)

^c Urology of Virginia   (United States)

Author keywords

Biomarker; Glycomics; Mass spectrometry; Prostate specific antigen; Prostatic acid phosphatase

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; GLYCAN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ABSORPTION CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; GLYCOBIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION TRAP MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SEMINAL PLASMA;

CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; GLYCOMICS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN TYROSINE PHOSPHATASES; SEMEN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 61849113322     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8007545     Document Type: Article

References (38)

1. Gann, P. H.; Hennekens, C. H.; Stampfer, M. J. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA, J. Am. Med. Assoc. 1995, 273 (4), 289-94.
2. Chan, D. W.; Sokoll, L. J. Prostate-specific antigen: update 1997. J. Int. Fed. Clin. Chem. 1997, 9 (3), 120-5.
3. Partin, A. W.; Oesterling, J. E. The clinical usefulness of percent free-PSA. Urology 1996, 48 (6A Suppl), 1-3.
4. Wilkinson, B. A.; Hamdy, F. C. State-of-the-art staging in prostate cancer. BJU Int. 2001, 87 (5), 423-30.
5. Makarov, D. V.; Carter, H. B. The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate. J. Urol. 2006, 176 (6 Pt 1), 2383-5.
6. Han, M.; Piantadosi, S.; Zahurak, M. L.; Sokoll, L. J.; Chan, D. W.; Epstein, J. I.; Walsh, P. C.; Partin, A. W. Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer. Urology 2001, 57 (4), 707-11.
7. Moul, J. W.; Connelly, R. R.; Perahia, B.; McLeod, D. G. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases. J. Urol. 1998, 159 (3), 935-40.
8. Stamey, T. A.; Yang, N.; Hay, A. R.; McNeal, J. E.; Freiha, F. S.; Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 1987, 317 (15), 909-16.
9. Jakob, C. G.; Lewinski, K.; Kuciel, R.; Ostrowski, W.; Lebioda, L. Crystal structure of human prostatic acid phosphatase. Prostate 2000, 42(3), 211-8.
10. Menez, R.; Michel, S.; Muller, B. H.; Bossus, M.; Ducancel, F.; Jolivet-Reynaud, G; Stura, E. A. Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody. J. Mol. Biol. 2008, 376 (4), 1021-33.
11. Couldrey, C.; Green, J. E. Metastases: the glycan connection. Breast Cancer Res. 2000, 2 (5), 321-3.
12. Dwek, M. V.; Ross, H. A.; Leathern, A. J. Proteome and glycosylation mapping identifies post-translational modifications associated with aggressive breast cancer. Proteolytics 2001, 1 (6), 756-62.
13. Fukuda, M. Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim. Biophys. Acta 1985, 780 (2), 119-50.
14. Dennis, J. W.; Laferte, S.; Waghome, C.; Breitman, M. L.; Kerbel, R. S. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236 (4801), 582-5.
15. Belanger, A.; van Halbeek, H.; Graves, H. C.; Grandbois, K.; Stamey, T. A.; Huang, L.; Poppe, I.; Labrie, F. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 1995, 27 (4), 187-97.
16. Armbruster, D. A. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin. Chem. 1993, 39 (2), 181-95.
17. Peracaula, R.; Tabares, G.; Royle, L.; Harvey, D. J.; Dwek, R. A.; Rudd, P. M.; de Llorens, R. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 2003, 13 (6), 457-70.
18. Prakash, S.; Robbins, P. W. Glycotyping of prostate specific antigen. Glycobiology 2000, 10 (2), 173-6.
19. Okada, T.; Sato, Y.; Kobayashi, N.; Sumida, K.; Satomura, S.; Matsuura, S.; Takasaki, M.; Endo, T. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid. Biochim. Biophys. Acta 2001, 1525 (1-2), 149-60.
20. Mattsson, J. M.; Valmu, L.; Laakkonen, P.; Stenman, U. H.; Koistinen, H. Structural characterization and anti-angiogenic properties of prostate-specific antigen isoforms in seminal fluid. Prostate 2008, 68 (9), 945-54.
21. Tabares, G.; Jung, K.; Reiche, J.; Stephan, C.; Lein, M.; Peracaula, R.; de Llorens, R.; Hoesel, W. Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples. Clin. Biochem. 2007, 40 (5-6), 343-50.
22. Tajiri, M.; Ohyama, C.; Wada, Y. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glyco-peptide approach. Glycobiology 2008, 18 (1), 2-8.
23. Yoshida, K. I.; Honda, M.; Arai, K.; Hosoya, Y.; Moriguchi, H.; Sumi, S.; Ueda, Y.; Kitahara, S. Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma. J. Chromatogr., B: Biomed. Sci. Appl. 1997, 695 (2), 439-43.
24. Kawinski, E.; Levine, E.; Chadha, K. Thiophilic interaction chromatography facilitates detection of various molecular complexes of prostate-specific antigen in biological fluids. Prostate 2002, 50 (3), 145-53.
25. Block, T. M.; Comunale, M. A.; Lowman, M.; Steel, L. F.; Romano, P. R.; Fimmel, C.; Tennant, B. C.; London, W. T.; Evans, A. A.; Blumberg, B. S.; Dwek, R. A.; Mattu, T. S.; Mehta, A. S. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. USA. 2005, 102 (3), 779-84.
26. Mehta, A.; Carrouee, S.; Conyers, B.; Jordan, R.; Butters, T.; Dwek, R. A.; Block, T. M. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatology 2001, 33 (6), 1488-95.
27. Guile, G. R.; Rudd, P. M.; Wing, D. R.; Prime, S. B.; Dwek, R. A. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 1996, 240 (2), 210-26.
28. Ciucanu, I.; Kerek, F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 1984, 131, 209-217.
29. Ceroni, A.; Dell, A.; Haslam, S. M. The GlycanBuilder: a fast, intuitive and flexible software tool for building and displaying glycan structures. Source Code Biol. Med. 2007, 2, 3.
30. Sandra, K.; Devreese, B.; Van Beeumen, J.; Stals, I.; Claeyssens, M. The Q-Trap mass spectrometer, a novel tool in the study of protein glycosylation. J. Am. Soc. Mass Spectrom. 2004, 15 (3), 413-23.
31. Carr, S. A.; Huddleston, M. J.; Bean, M. F. Selective identification and differentiation of N- and O-linked oligosaccharides in glycoproteins by liquid chromatography-mass spectrometry. Protein Sci. 1993, 2 (2), 183-96.
32. Tabares, G.; Radcliffe, C. M.; Barrabes, S.; Ramirez, M.; Aleixandre, R. N.; Hoesel, W.; Dwek, R. A.; Rudd, P. M.; Peracaula, R.; de Llorens, R. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 2006, 16 (2), 132-45.
33. Mehta, A. S.; Long, R. E.; Comunale, M. A.; Wang, M.; Rodemich, L.; Krakover, J.; Philip, R.; Marrero, J. A.; Dwek, R. A.; Block, T. M. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 2008, 82 (3), 1259-70.
34. Atwood, J. A., 3rd; Cheng, L.; Alvarez-Manilla, G.; Warren, N. L.; York, W. S.; Orlando, R. Quantitation by isobaric labeling: applications to glycomics. J. Proteome Res. 2008, 7 (1), 367-74.
35. Prien, J. M.; Huysentruyt, L. C.; Ashline, D. J.; Lapadula, A. J.; Seyfried, T. N.; Reinhold, V. N. Differentiating N-linked glycan structural isomers in metastatic and nonmetastatic tumor cells using sequential mass spectrometry. Glycobiology 2008, 18 (5), 353-66.
36. Wuhrer, M.; Catalina, M. I.; Deelder, A. M.; Hokke, C. H. Glycoproteomics based on tandem mass spectrometry of glycopeptides. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007, 849 (1-2), 115-28.
37. Hessels, D.; Smit, F. P.; Verhaegh, G. W.; Witjes, J. A.; Cornel, E. B.; Schalken, J. A. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin. Cancer Res. 2007, 13 (17), 5103-8.
38. Laxman, B.; Morris, D. S.; Yu, J.; Siddiqui, J.; Cao, J.; Mehra, R.; Lonigro, R. J.; Tsodikov, A.; Wei, J. T.; Tomlins, S. A.; Chinnaiyan, A. M. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 2008, 68 (3), 645-9.